MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, COGT has $903,006K in assets. $295,313K in debts. $241,208K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
1513.95%
Quick Ratio
1513.95%
Cash Ratio
416.01%
Debt to Asset Ratio
32.70%
Unit: Thousand (K) dollars
Assets Breakdown
    • Short-term marketable securities
    • Cash and cash equivalents
    • Operating lease, right-of-use as...
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Convertible senior notes, net
    • Others

Balance Sheets
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Cash and cash equivalents
241,208 312,012 125,297 127,598
Short-term marketable securities
625,170 588,753 265,593 110,250
Prepaid expenses and other current assets
11,425 9,590 6,354 7,160
Total current assets
877,803 910,355 397,244 245,008
Operating lease, right-of-use assets
17,549 18,078 18,591 19,097
Property and equipment, gross
-14,136 --
Accumulated depreciation
-8,679 --
Property and equipment, net
5,298 5,457 5,274 5,850
Restricted cash
416 416 336 -
Other assets
1,940 3,301 4,488 4,862
Total assets
903,006 937,607 425,933 274,817
Accounts payable
13,744 9,504 16,029 16,625
Accrued expenses and other current liabilities
42,854 52,902 44,511 40,139
Operating lease liabilities
1,383 1,547 1,706 1,658
Total current liabilities
57,981 63,953 62,246 58,422
Long-term debt, net
--44,250 43,949
Convertible senior notes, net
223,173 222,895 --
Operating lease liabilities, net of current portion
14,097 14,355 14,603 15,051
Other liabilities
62 33 2,370 2,359
Total liabilities
295,313 301,236 123,469 119,781
Preferred stock, value-Series ANon Voting Convertible Preferred Stock
29,190 53,830 53,830 53,830
Preferred stock, value
---0
Preferred stock, value-Series BNon Voting Convertible Preferred Stock
35,563 35,563 54,085 54,085
Common stock, 0.001 par value 300,000,000 shares authorized 170,773,803 and 160,980,024 shares issued and outstanding at march 31, 2026 and december 31, 2025, respectively
171 161 141 114
Additional paid-in capital
1,828,956 1,734,882 1,280,128 1,051,992
Accumulated other comprehensive income (loss)
-415 355 208 13
Accumulated deficit
-1,285,772 -1,188,420 -1,085,928 -1,004,998
Total stockholders equity
607,693 636,371 302,464 155,036
Total liabilities and stockholders equity
903,006 937,607 425,933 274,817
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Short-term marketablesecurities$625,170K Cash and cashequivalents$241,208K Prepaid expenses andother current assets$11,425K Total current assets$877,803K Operating lease,right-of-use assets$17,549K Property and equipment,net$5,298K Other assets$1,940K Restricted cash$416K Total assets$903,006K Total liabilities andstockholders equity$903,006K Total stockholdersequity$607,693K Total liabilities$295,313K Accumulated deficit-$1,285,772K Accumulated othercomprehensive income (loss)-$415K Additional paid-in capital$1,828,956K Convertible senior notes,net$223,173K Total currentliabilities$57,981K Operating leaseliabilities, net of current...$14,097K Other liabilities$62K Preferred stock,value-Series BNon Voting...$35,563K Preferred stock,value-Series ANon Voting...$29,190K Common stock, 0.001 parvalue 300,000,000...$171K Accrued expenses andother current...$42,854K Accounts payable$13,744K Operating leaseliabilities$1,383K

Cogent Biosciences, Inc. (COGT)

Cogent Biosciences, Inc. (COGT)